Last 12 months
Inside the activity.
0 purchase rows · 51 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 12 |
| Dec 2025 | 0 | 11 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 13 |
| Jun 2026 | 0 | 12 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 2 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 16, 2022 Filed Sep 19, 2022 23:27 UTC |
DOSSETT JEFFREYChief Revenue Officer
|
SaleCommon Stock | 120 | $88.37 | $10,604.20 |
DisclosureSEC source: 0001209191-22-050649 · doc4.xml · nonDerivative · entry 3 DOSSETT JEFFREY · CIK 0001578147 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,097 F1 · kind: These shares were disposed of in non-discretionary transactions to cover the reporting person's tax withholding obligations in connection with the settlement of an award of restricted stock units. F3 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $88.32 to $88.40, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. Read SEC document |
| September 16, 2022 Filed Sep 19, 2022 23:27 UTC |
DOSSETT JEFFREYChief Revenue Officer
|
SaleCommon Stock | 657 | $87.85 | $57,714.69 |
DisclosureSEC source: 0001209191-22-050649 · doc4.xml · nonDerivative · entry 2 DOSSETT JEFFREY · CIK 0001578147 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,217 F1 · kind: These shares were disposed of in non-discretionary transactions to cover the reporting person's tax withholding obligations in connection with the settlement of an award of restricted stock units. F2 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $87.1401 to $88.14, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. Read SEC document |
| September 16, 2022 Filed Sep 19, 2022 23:25 UTC |
DIORIO CHRIS PH.D.Director · Chief Executive Officer
|
SaleCommon Stock | 120 | $88.29 | $10,595.00 |
DisclosureSEC source: 0001209191-22-050647 · doc4.xml · nonDerivative · entry 3 DIORIO CHRIS PH.D. · CIK 0001677721 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 299,946 F1 · kind: These shares were disposed of in non-discretionary transactions to cover the reporting person's tax withholding obligations in connection with the settlement of an award of restricted stock units. F3 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $88.16 to $88.38, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. Read SEC document |
| September 16, 2022 Filed Sep 19, 2022 23:25 UTC |
DIORIO CHRIS PH.D.Director · Chief Executive Officer
|
SaleCommon Stock | 527 | $87.87 | $46,305.54 |
DisclosureSEC source: 0001209191-22-050647 · doc4.xml · nonDerivative · entry 2 DIORIO CHRIS PH.D. · CIK 0001677721 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 300,066 F1 · kind: These shares were disposed of in non-discretionary transactions to cover the reporting person's tax withholding obligations in connection with the settlement of an award of restricted stock units. F2 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $87.1401 to $88.14, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. Read SEC document |
| September 16, 2022 Filed Sep 19, 2022 23:24 UTC |
Baker CaryChief Financial Officer
|
SaleCommon Stock | 60 | $88.31 | $5,298.55 |
DisclosureSEC source: 0001209191-22-050644 · doc4.xml · nonDerivative · entry 3 Baker Cary · CIK 0001705407 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,569 F1 · kind: These shares were disposed of in non-discretionary transactions to cover the reporting person's tax withholding obligations in connection with the settlement of an award of restricted stock units. F3 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $88.17 to $88.405, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. Read SEC document |
| September 16, 2022 Filed Sep 19, 2022 23:24 UTC |
Baker CaryChief Financial Officer
|
SaleCommon Stock | 264 | $87.88 | $23,200.29 |
DisclosureSEC source: 0001209191-22-050644 · doc4.xml · nonDerivative · entry 2 Baker Cary · CIK 0001705407 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,629 F1 · kind: These shares were disposed of in non-discretionary transactions to cover the reporting person's tax withholding obligations in connection with the settlement of an award of restricted stock units. F2 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $87.1401 to $88.14, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. Read SEC document |
| September 15, 2022 Filed Sep 19, 2022 23:32 UTC |
MECKLAI HUSSEINChief Operating Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 468 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-050652 · doc4.xml · derivative · entry 6 MECKLAI HUSSEIN · CIK 0001908089 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,282 Underlying: Common Stock · 468 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Impinj common stock. F6 · derivative.exercise_date: On June 29, 2020, the reporting person was granted 7,500 restricted stock units ("RSUs"), one fourth of which vested on June 15, 2021, with an additional one-sixteenth of such RSUs vesting every three months thereafter. One-sixteenth of these RSUs vested on September 15, 2022. F6 · derivative.expiration_date: On June 29, 2020, the reporting person was granted 7,500 restricted stock units ("RSUs"), one fourth of which vested on June 15, 2021, with an additional one-sixteenth of such RSUs vesting every three months thereafter. One-sixteenth of these RSUs vested on September 15, 2022. Read SEC document |
| September 15, 2022 Filed Sep 19, 2022 23:32 UTC |
MECKLAI HUSSEINChief Operating Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 781 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-050652 · doc4.xml · derivative · entry 5 MECKLAI HUSSEIN · CIK 0001908089 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,469 Underlying: Common Stock · 781 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Impinj common stock. F5 · derivative.exercise_date: On June 15, 2020, the reporting person was granted 12,500 restricted stock units ("RSUs"), one fourth of which vested on June 15, 2021, with an additional one-sixteenth of such RSUs vesting every three months thereafter. One-sixteenth of these RSUs vested on September 15, 2022. F5 · derivative.expiration_date: On June 15, 2020, the reporting person was granted 12,500 restricted stock units ("RSUs"), one fourth of which vested on June 15, 2021, with an additional one-sixteenth of such RSUs vesting every three months thereafter. One-sixteenth of these RSUs vested on September 15, 2022. Read SEC document |
| September 15, 2022 Filed Sep 19, 2022 23:32 UTC |
MECKLAI HUSSEINChief Operating Officer
|
Exercise / conversionCommon Stock | 468 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-050652 · doc4.xml · nonDerivative · entry 2 MECKLAI HUSSEIN · CIK 0001908089 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,253 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 15, 2022 Filed Sep 19, 2022 23:32 UTC |
MECKLAI HUSSEINChief Operating Officer
|
Exercise / conversionCommon Stock | 781 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-050652 · doc4.xml · nonDerivative · entry 1 MECKLAI HUSSEIN · CIK 0001908089 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,785 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 15, 2022 Filed Sep 19, 2022 23:27 UTC |
DOSSETT JEFFREYChief Revenue Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 1,875 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-050649 · doc4.xml · derivative · entry 4 DOSSETT JEFFREY · CIK 0001578147 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,125 Underlying: Common Stock · 1,875 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Impinj common stock. F5 · derivative.exercise_date: On June 15, 2020, the reporting person was granted 30,000 restricted stock units ("RSUs"), one fourth of which vested on June 15, 2021, with an additional one-sixteenth of such RSUs vesting every three months thereafter. One-sixteenth of these RSUs vested on September 15, 2022. F5 · derivative.expiration_date: On June 15, 2020, the reporting person was granted 30,000 restricted stock units ("RSUs"), one fourth of which vested on June 15, 2021, with an additional one-sixteenth of such RSUs vesting every three months thereafter. One-sixteenth of these RSUs vested on September 15, 2022. Read SEC document |
| September 15, 2022 Filed Sep 19, 2022 23:27 UTC |
DOSSETT JEFFREYChief Revenue Officer
|
Exercise / conversionCommon Stock | 1,875 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-050649 · doc4.xml · nonDerivative · entry 1 DOSSETT JEFFREY · CIK 0001578147 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,874 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 15, 2022 Filed Sep 19, 2022 23:25 UTC |
DIORIO CHRIS PH.D.Director · Chief Executive Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 1,562 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-050647 · doc4.xml · derivative · entry 5 DIORIO CHRIS PH.D. · CIK 0001677721 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,938 Underlying: Common Stock · 1,562 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Impinj common stock. F5 · derivative.exercise_date: On June 15, 2020, the reporting person was granted 25,000 restricted stock units ("RSUs"), one fourth of which vested on June 15, 2021, with an additional one-sixteenth of such RSUs vesting every three months thereafter. One-sixteenth of these RSUs vested on September 15, 2022. F5 · derivative.expiration_date: On June 15, 2020, the reporting person was granted 25,000 restricted stock units ("RSUs"), one fourth of which vested on June 15, 2021, with an additional one-sixteenth of such RSUs vesting every three months thereafter. One-sixteenth of these RSUs vested on September 15, 2022. Read SEC document |
| September 15, 2022 Filed Sep 19, 2022 23:25 UTC |
DIORIO CHRIS PH.D.Director · Chief Executive Officer
|
Exercise / conversionCommon Stock | 1,562 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-050647 · doc4.xml · nonDerivative · entry 1 DIORIO CHRIS PH.D. · CIK 0001677721 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 300,593 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 15, 2022 Filed Sep 19, 2022 23:24 UTC |
Baker CaryChief Financial Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 781 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-050644 · doc4.xml · derivative · entry 4 Baker Cary · CIK 0001705407 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,469 Underlying: Common Stock · 781 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Impinj common stock. F5 · derivative.exercise_date: On June 15, 2020, the reporting person was granted 12,500 restricted stock units ("RSUs"), one fourth of which vested on June 15, 2021, with an additional one-sixteenth of such RSUs vesting every three months thereafter. One-sixteenth of these RSUs vested on September 15, 2022. F5 · derivative.expiration_date: On June 15, 2020, the reporting person was granted 12,500 restricted stock units ("RSUs"), one fourth of which vested on June 15, 2021, with an additional one-sixteenth of such RSUs vesting every three months thereafter. One-sixteenth of these RSUs vested on September 15, 2022. Read SEC document |
| September 15, 2022 Filed Sep 19, 2022 23:24 UTC |
Baker CaryChief Financial Officer
|
Exercise / conversionCommon Stock | 781 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-050644 · doc4.xml · nonDerivative · entry 1 Baker Cary · CIK 0001705407 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,893 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 09, 2022 Filed Sep 9, 2022 21:14 UTC |
SESSLER GREGORYDirector
|
SaleCommon Stock | 670 | $92.16 | $61,745.46 |
DisclosureSEC source: 0001209191-22-049348 · doc4.xml · nonDerivative · entry 1 SESSLER GREGORY · CIK 0001285810 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,907 F1 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $92.12 to $92.165, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. Read SEC document |
| September 01, 2022 Filed Sep 6, 2022 20:45 UTC |
DOSSETT JEFFREYChief Revenue Officer
|
SaleCommon Stock | 2,000 | $88.05 | $176,100.00 |
DisclosureSEC source: 0001209191-22-048775 · doc4.xml · nonDerivative · entry 1 DOSSETT JEFFREY · CIK 0001578147 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,999 F1 · kind: The sales reported by Mr. Dossett were effected pursuant to a Rule 10b5-1 trading plan effective on February 11, 2022. Read SEC document |
| August 25, 2022 Filed Aug 26, 2022 20:38 UTC |
Baker CaryChief Financial Officer
|
SaleCommon Stock | 1,452 | $95.55 | $138,742.81 |
DisclosureSEC source: 0001209191-22-047718 · doc4.xml · nonDerivative · entry 2 Baker Cary · CIK 0001705407 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,112 F1 · kind: These shares were disposed of in non-discretionary transactions to cover the reporting person's tax withholding obligations in connection with the settlement of an award of RSUs. F2 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $95.055 to $95.925, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. Read SEC document |
| August 24, 2022 Filed Aug 26, 2022 20:38 UTC |
Baker CaryChief Financial Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 3,750 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-047718 · doc4.xml · derivative · entry 3 Baker Cary · CIK 0001705407 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,500 Underlying: Common Stock · 3,750 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Impinj common stock. F4 · derivative.exercise_date: On February 24, 2020, the reporting person was granted 60,000 restricted stock units ("RSUs"), one sixteenth of which vested on August 24, 2022. F4 · derivative.expiration_date: On February 24, 2020, the reporting person was granted 60,000 restricted stock units ("RSUs"), one sixteenth of which vested on August 24, 2022. Read SEC document |
| August 24, 2022 Filed Aug 26, 2022 20:38 UTC |
Baker CaryChief Financial Officer
|
Exercise / conversionCommon Stock | 3,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-047718 · doc4.xml · nonDerivative · entry 1 Baker Cary · CIK 0001705407 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,564 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 23, 2022 Filed Aug 23, 2022 22:13 UTC |
DIORIO CHRIS PH.D.Director · Chief Executive Officer
|
SaleCommon Stock | 50 | $93.88 | $4,694.00 |
DisclosureSEC source: 0001209191-22-047249 · doc4.xml · nonDerivative · entry 7 DIORIO CHRIS PH.D. · CIK 0001677721 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 299,031 F1 · kind: The sales reported by Dr. Diorio were effected pursuant to a Rule 10b5-1 trading plan adopted on May 27, 2022. Read SEC document |
| August 23, 2022 Filed Aug 23, 2022 22:13 UTC |
DIORIO CHRIS PH.D.Director · Chief Executive Officer
|
SaleCommon Stock | 2,003 | $93.20 | $186,679.40 |
DisclosureSEC source: 0001209191-22-047249 · doc4.xml · nonDerivative · entry 6 DIORIO CHRIS PH.D. · CIK 0001677721 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 299,081 F1 · kind: The sales reported by Dr. Diorio were effected pursuant to a Rule 10b5-1 trading plan adopted on May 27, 2022. F7 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $92.71 to $93.68, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. Read SEC document |
| August 23, 2022 Filed Aug 23, 2022 22:13 UTC |
DIORIO CHRIS PH.D.Director · Chief Executive Officer
|
SaleCommon Stock | 2,947 | $92.06 | $271,294.34 |
DisclosureSEC source: 0001209191-22-047249 · doc4.xml · nonDerivative · entry 5 DIORIO CHRIS PH.D. · CIK 0001677721 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 301,084 F1 · kind: The sales reported by Dr. Diorio were effected pursuant to a Rule 10b5-1 trading plan adopted on May 27, 2022. F6 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $91.64 to $92.56, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. Read SEC document |
| August 22, 2022 Filed Aug 23, 2022 22:13 UTC |
DIORIO CHRIS PH.D.Director · Chief Executive Officer
|
SaleCommon Stock | 745 | $93.78 | $69,867.81 |
DisclosureSEC source: 0001209191-22-047249 · doc4.xml · nonDerivative · entry 4 DIORIO CHRIS PH.D. · CIK 0001677721 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 304,031 F1 · kind: The sales reported by Dr. Diorio were effected pursuant to a Rule 10b5-1 trading plan adopted on May 27, 2022. F5 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $93.32 to $94.05, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. Read SEC document |
| August 22, 2022 Filed Aug 23, 2022 22:13 UTC |
DIORIO CHRIS PH.D.Director · Chief Executive Officer
|
SaleCommon Stock | 1,235 | $92.84 | $114,652.21 |
DisclosureSEC source: 0001209191-22-047249 · doc4.xml · nonDerivative · entry 3 DIORIO CHRIS PH.D. · CIK 0001677721 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 304,776 F1 · kind: The sales reported by Dr. Diorio were effected pursuant to a Rule 10b5-1 trading plan adopted on May 27, 2022. F4 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $92.20 to $93.13, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. Read SEC document |
| August 22, 2022 Filed Aug 23, 2022 22:13 UTC |
DIORIO CHRIS PH.D.Director · Chief Executive Officer
|
SaleCommon Stock | 2,220 | $91.64 | $203,441.24 |
DisclosureSEC source: 0001209191-22-047249 · doc4.xml · nonDerivative · entry 2 DIORIO CHRIS PH.D. · CIK 0001677721 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 306,011 F1 · kind: The sales reported by Dr. Diorio were effected pursuant to a Rule 10b5-1 trading plan adopted on May 27, 2022. F3 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $91.15 to $92.05, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. Read SEC document |
| August 22, 2022 Filed Aug 23, 2022 22:13 UTC |
DIORIO CHRIS PH.D.Director · Chief Executive Officer
|
SaleCommon Stock | 800 | $90.58 | $72,462.16 |
DisclosureSEC source: 0001209191-22-047249 · doc4.xml · nonDerivative · entry 1 DIORIO CHRIS PH.D. · CIK 0001677721 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 308,231 F1 · kind: The sales reported by Dr. Diorio were effected pursuant to a Rule 10b5-1 trading plan adopted on May 27, 2022. F2 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $90.01 to $91.00, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. Read SEC document |
| August 17, 2022 Filed Aug 18, 2022 20:36 UTC |
DIORIO CHRIS PH.D.Director · Chief Executive Officer
|
SaleCommon Stock | 450 | $96.56 | $43,452.27 |
DisclosureSEC source: 0001209191-22-046636 · doc4.xml · nonDerivative · entry 7 DIORIO CHRIS PH.D. · CIK 0001677721 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 309,031 F1 · kind: The sales reported by Dr. Diorio were effected pursuant to a Rule 10b5-1 trading plan adopted on May 27, 2022. F7 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $96.43 to $96.715, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. Read SEC document |
| August 17, 2022 Filed Aug 18, 2022 20:36 UTC |
DIORIO CHRIS PH.D.Director · Chief Executive Officer
|
SaleCommon Stock | 2,063 | $95.99 | $198,024.48 |
DisclosureSEC source: 0001209191-22-046636 · doc4.xml · nonDerivative · entry 6 DIORIO CHRIS PH.D. · CIK 0001677721 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 309,481 F1 · kind: The sales reported by Dr. Diorio were effected pursuant to a Rule 10b5-1 trading plan adopted on May 27, 2022. F6 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $95.43 to $96.415, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. Read SEC document |
| August 17, 2022 Filed Aug 18, 2022 20:36 UTC |
DIORIO CHRIS PH.D.Director · Chief Executive Officer
|
SaleCommon Stock | 1,486 | $94.95 | $141,090.20 |
DisclosureSEC source: 0001209191-22-046636 · doc4.xml · nonDerivative · entry 5 DIORIO CHRIS PH.D. · CIK 0001677721 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 311,544 F1 · kind: The sales reported by Dr. Diorio were effected pursuant to a Rule 10b5-1 trading plan adopted on May 27, 2022. F5 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $94.43 to $95.425, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. Read SEC document |
| August 17, 2022 Filed Aug 18, 2022 20:36 UTC |
DIORIO CHRIS PH.D.Director · Chief Executive Officer
|
SaleCommon Stock | 1,001 | $94.06 | $94,151.16 |
DisclosureSEC source: 0001209191-22-046636 · doc4.xml · nonDerivative · entry 4 DIORIO CHRIS PH.D. · CIK 0001677721 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 313,030 F1 · kind: The sales reported by Dr. Diorio were effected pursuant to a Rule 10b5-1 trading plan adopted on May 27, 2022. F4 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $93.43 to $94.395, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. Read SEC document |
| August 16, 2022 Filed Aug 18, 2022 20:36 UTC |
DIORIO CHRIS PH.D.Director · Chief Executive Officer
|
SaleCommon Stock | 200 | $97.22 | $19,444.00 |
DisclosureSEC source: 0001209191-22-046636 · doc4.xml · nonDerivative · entry 3 DIORIO CHRIS PH.D. · CIK 0001677721 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 314,031 F1 · kind: The sales reported by Dr. Diorio were effected pursuant to a Rule 10b5-1 trading plan adopted on May 27, 2022. Read SEC document |
| August 16, 2022 Filed Aug 18, 2022 20:36 UTC |
DIORIO CHRIS PH.D.Director · Chief Executive Officer
|
SaleCommon Stock | 3,119 | $96.51 | $301,018.43 |
DisclosureSEC source: 0001209191-22-046636 · doc4.xml · nonDerivative · entry 2 DIORIO CHRIS PH.D. · CIK 0001677721 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 314,231 F1 · kind: The sales reported by Dr. Diorio were effected pursuant to a Rule 10b5-1 trading plan adopted on May 27, 2022. F3 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $96.22 to $97.15, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. Read SEC document |
| August 16, 2022 Filed Aug 18, 2022 20:36 UTC |
DIORIO CHRIS PH.D.Director · Chief Executive Officer
|
SaleCommon Stock | 1,681 | $95.82 | $161,073.76 |
DisclosureSEC source: 0001209191-22-046636 · doc4.xml · nonDerivative · entry 1 DIORIO CHRIS PH.D. · CIK 0001677721 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 317,350 F1 · kind: The sales reported by Dr. Diorio were effected pursuant to a Rule 10b5-1 trading plan adopted on May 27, 2022. F2 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $95.21 to $96.20, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. Read SEC document |
| August 03, 2022 Filed Aug 3, 2022 23:38 UTC |
MECKLAI HUSSEINChief Operating Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 9,000 | $0.00 Strike: $17.75 | $0.00 |
DisclosureSEC source: 0001209191-22-044330 · doc4.xml · derivative · entry 3 MECKLAI HUSSEIN · CIK 0001908089 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,384 Underlying: Common Stock · 9,000 shares Expires 2028-12-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: One-fourth of the shares subject to the option vested on December 5, 2019, and 1/48th of the shares subject to the option shall vest each month thereafter, subject to the Reporting Person's continued service to the Issuer through such date. Read SEC document |
| August 03, 2022 Filed Aug 3, 2022 23:38 UTC |
MECKLAI HUSSEINChief Operating Officer
|
SaleCommon Stock | 9,000 | $89.00 | $801,000.90 |
DisclosureSEC source: 0001209191-22-044330 · doc4.xml · nonDerivative · entry 2 MECKLAI HUSSEIN · CIK 0001908089 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,004 F1 · kind: The sales reported by Mr. Mecklai were effected pursuant to a Rule 10b5-1 trading plan effective on February 11, 2022. F2 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $89.00 to $89.06, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. Read SEC document |
| August 03, 2022 Filed Aug 3, 2022 23:38 UTC |
MECKLAI HUSSEINChief Operating Officer
|
Exercise / conversionCommon Stock | 9,000 | $17.75 | $159,750.00 |
DisclosureSEC source: 0001209191-22-044330 · doc4.xml · nonDerivative · entry 1 MECKLAI HUSSEIN · CIK 0001908089 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,004 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 03, 2022 Filed Aug 3, 2022 23:33 UTC |
Baker CaryChief Financial Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 3,000 | $0.00 Strike: $26.84 | $0.00 |
DisclosureSEC source: 0001209191-22-044328 · doc4.xml · derivative · entry 3 Baker Cary · CIK 0001705407 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,500 Underlying: Common Stock · 3,000 shares Expires 2030-06-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: One-fourth of the shares subject to the option shall vest on June 15, 2021, and 1/48th of the shares subject to the option shall vest each month thereafter, subject to the Reporting Person's continued service to the Issuer through such date. Read SEC document |
| August 03, 2022 Filed Aug 3, 2022 23:33 UTC |
Baker CaryChief Financial Officer
|
SaleCommon Stock | 3,000 | $90.02 | $270,074.10 |
DisclosureSEC source: 0001209191-22-044328 · doc4.xml · nonDerivative · entry 2 Baker Cary · CIK 0001705407 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,814 F1 · kind: The sales reported by Mr. Baker were effected pursuant to a Rule 10b5-1 trading plan effective on February 11, 2022. F2 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $90.00 to $90.14, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. Read SEC document |
| August 03, 2022 Filed Aug 3, 2022 23:33 UTC |
Baker CaryChief Financial Officer
|
Exercise / conversionCommon Stock | 3,000 | $26.84 | $80,520.00 |
DisclosureSEC source: 0001209191-22-044328 · doc4.xml · nonDerivative · entry 1 Baker Cary · CIK 0001705407 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,814 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 01, 2022 Filed Aug 2, 2022 00:24 UTC |
MECKLAI HUSSEINChief Operating Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 156 | $0.00 Strike: $26.62 | $0.00 |
DisclosureSEC source: 0001209191-22-043782 · doc4.xml · derivative · entry 20 MECKLAI HUSSEIN · CIK 0001908089 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,594 Underlying: Common Stock · 156 shares Expires 2030-06-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: One-fourth of the shares subject to the option vested on June 15, 2021, and 1/48th of the shares subject to the option shall vest each month thereafter, subject to the Reporting Person's continued service to the Issuer through such date. Read SEC document |
| August 01, 2022 Filed Aug 2, 2022 00:24 UTC |
MECKLAI HUSSEINChief Operating Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 260 | $0.00 Strike: $26.84 | $0.00 |
DisclosureSEC source: 0001209191-22-043782 · doc4.xml · derivative · entry 19 MECKLAI HUSSEIN · CIK 0001908089 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,990 Underlying: Common Stock · 260 shares Expires 2030-06-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: One-fourth of the shares subject to the option vested on June 15, 2021, and 1/48th of the shares subject to the option shall vest each month thereafter, subject to the Reporting Person's continued service to the Issuer through such date. Read SEC document |
| August 01, 2022 Filed Aug 2, 2022 00:24 UTC |
MECKLAI HUSSEINChief Operating Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 209 | $0.00 Strike: $36.20 | $0.00 |
DisclosureSEC source: 0001209191-22-043782 · doc4.xml · derivative · entry 18 MECKLAI HUSSEIN · CIK 0001908089 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,500 Underlying: Common Stock · 209 shares Expires 2029-07-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: One-fourth of the shares subject to the option vested July 31, 2020, and 1/48th of the shares subject to the option shall vest each month thereafter, subject to the Reporting Person's continued service to the Issuer through such date. Read SEC document |
| August 01, 2022 Filed Aug 2, 2022 00:24 UTC |
MECKLAI HUSSEINChief Operating Officer
|
SaleCommon Stock | 246 | $85.32 | $20,989.88 |
DisclosureSEC source: 0001209191-22-043782 · doc4.xml · nonDerivative · entry 12 MECKLAI HUSSEIN · CIK 0001908089 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,004 F2 · kind: These shares were disposed of in non-discretionary transactions to cover the reporting person's tax withholding obligations in connection with the settlement of an award of restricted stock units. F3 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $85.27 to $85.53, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. Read SEC document |
| August 01, 2022 Filed Aug 2, 2022 00:24 UTC |
MECKLAI HUSSEINChief Operating Officer
|
SaleCommon Stock | 625 | $82.33 | $51,456.25 |
DisclosureSEC source: 0001209191-22-043782 · doc4.xml · nonDerivative · entry 11 MECKLAI HUSSEIN · CIK 0001908089 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,250 F1 · kind: The sales reported by Mr. Mecklai were effected pursuant to a Rule 10b5-1 trading plan effective on February 11, 2022. Read SEC document |
| August 01, 2022 Filed Aug 2, 2022 00:24 UTC |
MECKLAI HUSSEINChief Operating Officer
|
Exercise / conversionCommon Stock | 156 | $26.62 | $4,152.72 |
DisclosureSEC source: 0001209191-22-043782 · doc4.xml · nonDerivative · entry 10 MECKLAI HUSSEIN · CIK 0001908089 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,875 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 01, 2022 Filed Aug 2, 2022 00:24 UTC |
MECKLAI HUSSEINChief Operating Officer
|
Exercise / conversionCommon Stock | 260 | $26.84 | $6,978.40 |
DisclosureSEC source: 0001209191-22-043782 · doc4.xml · nonDerivative · entry 9 MECKLAI HUSSEIN · CIK 0001908089 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,719 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 01, 2022 Filed Aug 2, 2022 00:24 UTC |
MECKLAI HUSSEINChief Operating Officer
|
Exercise / conversionCommon Stock | 209 | $36.20 | $7,565.80 |
DisclosureSEC source: 0001209191-22-043782 · doc4.xml · nonDerivative · entry 8 MECKLAI HUSSEIN · CIK 0001908089 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,459 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 01, 2022 Filed Aug 2, 2022 21:19 UTC |
DOSSETT JEFFREYChief Revenue Officer
|
SaleCommon Stock | 6,000 | $82.33 | $493,980.00 |
DisclosureSEC source: 0001209191-22-043940 · doc4.xml · nonDerivative · entry 3 DOSSETT JEFFREY · CIK 0001578147 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,999 F3 · kind: The sales reported by Mr. Dossett were effected pursuant to a Rule 10b5-1 trading plan effective on February 11, 2022. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.